Skip To Main Content
Noam Barda on Muck Rack

Noam Barda

As seen in: Nature, Wiley Online Library, PLOS, JAMA (The Journal of the American Medical Association), The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Noam

Contact Noam, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological data

|
By Julia Deichmann, Noam Barda, Michal Canetti, Yovel Peretz
| PLOS
Loading metrics Open Access Peer-reviewed Research Article ? This is an uncorrected proof. Citation: Deichmann J, Barda N, Canetti M, Peretz Y, Weiss-Ottolenghi Y, Lustig Y, et al. (2025) Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological data. PLoS Comput Biol 21(6): e1013192. https://doi.org/10.1371/journal.pcbi.1013192 Editor: David S.
Open in Who Shared Issue with article?

Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines

|
By Tal Gonen, Tel Hashomer, Ramat Gan, Noam Barda
| JAMA (The Journal of the American Medical Association) Verified
Key Points Question Is the coadministration of a COVID-19 vaccine with a seasonal influenza vaccine safe and efficacious? Findings This prospective cohort study included health care workers vaccinated against COVID-19 and/or influenza. Compared with COVID-19 vaccination alone, the risk of systemic symptoms was lower and statistically insignificant in the coadministration group. Lower, statistically insignificant anti-spike IgG titers were found in the coadministration group.
Open in Who Shared Issue with article?

Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up - Nature Communications

|
By Michal Canetti, Noam Barda, Laurence S Freedman
| Nature Verified
Correction to: Nature Communications https://doi.org/10.1038/s41467-022-35480-2, published online 13 December 2022 The published version of the article contained an error in Figure 2, where the incorrect panel d had been included. This has been corrected in the HTML and PDF versions.
Open in Who Shared Issue with article?
See all 13 articles